Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1973;48:823-829

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DONNELLY, R. J.
Right arrow Articles by WATSON, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DONNELLY, R. J.
Right arrow Articles by WATSON, D. A.

(Circulation. 1973;48:823.)
© 1973 American Heart Association, Inc.


Chronic Hemolysis Following Mitral Valve Replacement

A Comparison of the Frame-Mounted Aortic Homograft and the Composite Seat Starr-Edwards Prosthesis

R. J. DONNELLY M.B., F.R.C.S.E.1; A. N. RAHMAN M.B.B.S.1; S. M. MANOHITHARAJAH M.B., M.R.C.P., M.R.C.P.E.1; P. B. DEVERALL M.B., F.R.C.S.1; D. A. WATSON M.B., F.R.C.S.1

1 From the Leeds Regional Thoracic Surgical Centre and Department of Haematology, Killingbeck Hospital, Leeds, England.

The incidence and severity of chronic intravascular hemolysis was evaluated in a total of 41 patients following mitral valve replacement. Valve replacement was with a gamma-radiated frame-mounted aortic homograft in 21 patients and with a composite seat Starr-Edwards prosthesis, model 6310 or 6320, in 20 patients. The parameters used to assess hemolysis were hemoglobin, hematocrit, reticulocyte count, red cell fragment count, serum haptoglobin, LDH and HBD, hemosiderin in the urine and red cell survival. The degree of hemolysis was classified as mild, moderate or severe. In the prosthetic valve group 85% showed evidence of chronic intravascular hemolysis, of which a third were mild and the rest moderate. The homograft patients did not show any comparable evidence of hemolysis. Statistical analysis of the comparative figures of the parameters used to assess hemolysis in the two groups of patients revealed a significant difference (P < 0.01) in hemoglobin and hematocrit and a highly significant difference (P < .001) in serum haptoglobins, hemosiderin in the urine, LDH, reticulocyte count, red cell fragment count and red cell survivals.


Key Words: Cardiac hemolytic anemia • Hemosiderinuria • Haptoglobin • Frame-mounted homograft valves • Lactic dehydrogenase • Red cell survival

Submitted on April 9, 1973
Accepted on May 17, 1973




This article has been cited by other articles:


Home page
CLIN PEDIATRHome page
A. Khanna, R. Tandon, A.K. Basu, and S. Shrivastava
Red Blood Cell Survival in Patients with Ventricular Septal Defect and Patent Ductus Arteriosus
Clinical Pediatrics, May 1, 1981; 20(5): 349 - 353.
[Abstract] [PDF]